Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat
- 26 March 2003
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 167 (2) , 115-122
- https://doi.org/10.1007/s00213-002-1368-8
Abstract
Antipsychotic drugs, particularly the newer atypical compounds, have been associated with rapid weight gain in a clinical setting. However, there are few reported animal models producing reliable hyperphagia correlating with the human weight gain liability of these drugs. To compare the effects of the classic neuroleptic haloperidol with the atypical antipsychotics clozapine and olanzapine on the microstructure of ingestive behaviour in rats. Male hooded Lister rats drank a palatable high-calorie fat emulsion (10% Intralipid) during 30-min test sessions and microstructural analyses were made following administration of each drug over a range of doses. Clozapine (0.3 mg/kg) and olanzapine (0.1, 0.3, 1 mg/kg) significantly increased intake, whilst haloperidol (0.05, 0.1, 0.2 mg/kg) significantly decreased drinking. No significant changes in the latency to the first lick were observed following any of the drugs tested. Median interlick intervals showed small, dose-related increases after clozapine (3.0 mg/kg), olanzapine (0.3, 1.0 mg/kg) and haloperidol (0.1, 0.2 mg/kg). Olanzapine (1.0 mg/kg) significantly elevated the number of clusters of licking (bouts of licking separated by pauses greater than 500 ms), whilst clozapine and haloperidol did not. Mean cluster size (licks per cluster) was not affected by clozapine or olanzapine, but haloperidol (0.025, 0.05, 0.1, 0.2 mg/kg) produced marked, significant decreases in cluster size. Clozapine and olanzapine increased fat intake whereas haloperidol did not, and this resembles the greater weight gain liability of atypical antipsychotics in humans. A delay or reduction of the post-ingestive satiety signal combined with preserved palatability appears to be the mechanism responsible for fat hyperphagia in rats treated with clozapine and olanzapine. Conversely, haloperidol leaves satiety unaffected but reduces the palatability of the fat emulsion resulting in reduced intake.Keywords
This publication has 35 references indexed in Scilit:
- Dopamine D2 Receptor Blockade by Haloperidol 3H-Raclopride Reveals Much Higher Occupancy than EEDQNeuropsychopharmacology, 2000
- Analytical issues in the evaluation of food deprivation and sucrose concentration effects on the microstructure of licking behavior in the rat.Behavioral Neuroscience, 1998
- Analytical issues in the evaluation of food deprivation and sucrose concentration effects on the microstructure of licking behavior in the rat.Behavioral Neuroscience, 1998
- Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?Obesity Research, 1995
- Effects of long-term administration of clozapine on body weight and food intake in ratsPharmacology Biochemistry and Behavior, 1993
- Role of dietary fat in calorie intake and weight gainNeuroscience & Biobehavioral Reviews, 1992
- Analysis of the microstructure of the rhythmic tongue movements of rats ingesting maltose and sucrose solutions.Behavioral Neuroscience, 1992
- A Clinical Trial of the Efficacy and Acceptability of d-Fenfluramine in the Treatment of Neuroleptic-induced ObesityThe British Journal of Psychiatry, 1988
- Pimozide decreases the positive reinforcing effect of sham fed sucrose in the ratPharmacology Biochemistry and Behavior, 1985
- The effectiveness of some sugars in stimulating licking behavior in the ratPhysiology & Behavior, 1973